PortfoliosLab logoPortfoliosLab logo
KRRO vs. PRAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KRRO vs. PRAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Frequency Therapeutics Inc (KRRO) and Praxis Precision Medicines, Inc. (PRAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KRRO achieves a 38.33% return, which is significantly higher than PRAX's -5.36% return.


KRRO

1D
0.73%
1M
-14.97%
YTD
38.33%
6M
83.44%
1Y
-7.12%
3Y*
5Y*
10Y*

PRAX

1D
8.08%
1M
-17.38%
YTD
-5.36%
6M
49.84%
1Y
577.01%
3Y*
164.05%
5Y*
-0.71%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

KRRO vs. PRAX - Yearly Performance Comparison


2026 (YTD)202520242023
KRRO
Frequency Therapeutics Inc
38.33%-78.96%-20.57%209.63%
PRAX
Praxis Precision Medicines, Inc.
-5.36%282.98%245.42%50.67%

Correlation

The correlation between KRRO and PRAX is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Nov 7, 2023

0.24

Fundamentals

Market Cap

KRRO:

$128.51M

PRAX:

$8.06B

EPS

KRRO:

-$11.41

PRAX:

-$13.77

PB Ratio

KRRO:

1.07

PRAX:

5.71

Total Revenue (TTM)

KRRO:

$3.84M

PRAX:

-$92.00K

Gross Profit (TTM)

KRRO:

$3.19M

PRAX:

-$128.83M

EBITDA (TTM)

KRRO:

-$78.53M

PRAX:

-$344.68M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KRRO vs. PRAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KRRO
KRRO Risk / Return Rank: 4848
Overall Rank
KRRO Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
KRRO Sortino Ratio Rank: 5959
Sortino Ratio Rank
KRRO Omega Ratio Rank: 6767
Omega Ratio Rank
KRRO Calmar Ratio Rank: 3838
Calmar Ratio Rank
KRRO Martin Ratio Rank: 3939
Martin Ratio Rank

PRAX
PRAX Risk / Return Rank: 9898
Overall Rank
PRAX Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
PRAX Sortino Ratio Rank: 9999
Sortino Ratio Rank
PRAX Omega Ratio Rank: 9898
Omega Ratio Rank
PRAX Calmar Ratio Rank: 9999
Calmar Ratio Rank
PRAX Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KRRO vs. PRAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Frequency Therapeutics Inc (KRRO) and Praxis Precision Medicines, Inc. (PRAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


KRROPRAXDifference

Sharpe ratio

Return per unit of total volatility

-0.06

2.93

-2.99

Sortino ratio

Return per unit of downside risk

1.21

6.64

-5.43

Omega ratio

Gain probability vs. loss probability

1.20

1.86

-0.66

Calmar ratio

Return relative to maximum drawdown

-0.08

16.02

-16.10

Martin ratio

Return relative to average drawdown

-0.12

50.51

-50.63

KRRO vs. PRAX - Sharpe Ratio Comparison

The current KRRO Sharpe Ratio is -0.06, which is lower than the PRAX Sharpe Ratio of 2.93. The chart below compares the historical Sharpe Ratios of KRRO and PRAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


KRROPRAXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.06

2.93

-2.99

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.09

-0.06

-0.03

Drawdowns

KRRO vs. PRAX - Drawdown Comparison

The maximum KRRO drawdown since its inception was -94.13%, roughly equal to the maximum PRAX drawdown of -98.67%. Use the drawdown chart below to compare losses from any high point for KRRO and PRAX.


Loading charts...

Drawdown Indicators


KRROPRAXDifference

Max Drawdown

Largest peak-to-trough decline

-94.13%

-98.67%

+4.54%

Max Drawdown (1Y)

Largest decline over 1 year

-89.72%

-36.33%

-53.39%

Max Drawdown (3Y)

Largest decline over 3 years

-68.64%

Max Drawdown (5Y)

Largest decline over 5 years

-96.50%

Current Drawdown

Current decline from peak

-87.69%

-69.11%

-18.58%

Average Drawdown

Average peak-to-trough decline

-59.09%

-80.66%

+21.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

59.78%

11.50%

+48.28%

Volatility

KRRO vs. PRAX - Volatility Comparison

Frequency Therapeutics Inc (KRRO) and Praxis Precision Medicines, Inc. (PRAX) have volatilities of 31.24% and 30.10%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KRROPRAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

31.24%

30.10%

+1.14%

Volatility (6M)

Calculated over the trailing 6-month period

59.32%

54.82%

+4.50%

Volatility (1Y)

Calculated over the trailing 1-year period

124.96%

198.58%

-73.62%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

135.87%

127.54%

+8.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

135.87%

124.23%

+11.64%

Dividends

KRRO vs. PRAX - Dividend Comparison

Neither KRRO nor PRAX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

KRRO vs. PRAX - Financials Comparison

This section allows you to compare key financial metrics between Frequency Therapeutics Inc and Praxis Precision Medicines, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00M4.00M6.00M8.00M10.00M2022202320242025202600
(KRRO) Total Revenue
(PRAX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


KRRO and PRAX have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KRRO has higher volatility (31.24%) compared to PRAX (30.10%). In terms of maximum drawdown, KRRO dropped -94.13% vs PRAX's -98.67%.

PRAX currently has the higher Sharpe Ratio (2.93 vs -0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KRRO and PRAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer